ISIS PHARMACEUTICAL

BE:ISI Germany Other

Market Cap

$625.47K

€609.34K EUR

Market Cap Rank

#37006 Global

#4671 in Germany

Share Price

€67.36

Change (1 day)

-0.03%

52-Week Range

€22.50 - €70.66

All Time High

€75.98

ISIS PHARMACEUTICAL - Asset Resilience Ratio

Latest as of September 2024: 69.74%

ISIS PHARMACEUTICAL (ISI) has an Asset Resilience Ratio of 69.74% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€2.15 Billion

Cash + Short-term Investments

Total Assets

€3.08 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how ISIS PHARMACEUTICAL's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down ISIS PHARMACEUTICAL's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€2.15 Billion	69.74%
Total Liquid Assets	€2.15 Billion	69.74%

Asset Resilience Insights

Very High Liquidity: ISIS PHARMACEUTICAL maintains exceptional liquid asset reserves at 69.74% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.